DNA and RNA Synthesizer Research:CAGR of 3.9% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "DNA and RNA Synthesizer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global DNA and RNA Synthesizer market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for DNA and RNA Synthesizer was estimated to be worth US$ 303 million in 2025 and is projected to reach US$ 395 million, growing at a CAGR of 3.9% from 2026 to 2032.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5912631/dna-and-rna-synthesizer

DNA and RNA Synthesizer Product Introduction

A DNA and RNA synthesizer is an instrument used in laboratories to create synthetic DNA and RNA molecules. In simpler terms, it's like a specialized printer that, instead of ink, uses nucleotides (the building blocks of DNA and RNA) to "print" desired genetic sequences.

According to the new market research report "Global DNA and RNA Synthesizer Market Report 2025-2031", published by QYResearch, the global DNA and RNA Synthesizer market size is projected to reach USD 0.38 billion by 2031, at a CAGR of 3.9% during the forecast period.

Figure00001. Global DNA and RNA Synthesizer Market Size (US$ Million), 2025 VS 2031

DNA and RNA Synthesizer

Above data is based on report from QYResearch: Global DNA and RNA Synthesizer Market Report 2025-2031 (published in 2024). If you need the latest data, plaese contact QYResearch.

Figure00002. Global DNA and RNA Synthesizer Top 9 Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)

DNA and RNA Synthesizer

Above data is based on report from QYResearch: Global DNA and RNA Synthesizer Market Report 2025-2031 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of DNA and RNA Synthesizer include Kilobaser, Polygen GmbH, Biolytic Lab Performance, K&A Labs GmbH, BIOSSET Ltd., CSBio, Cytiva, LGC Biosearch Technologies, Hunan Honya Biotech Co., Ltd. etc. DNA and RNA synthesizer manufacturing is concentrated in North America and Western Europe, with significant production and assembly growth in East Asia, because these regions have strong life-science instrument ecosystems, mature precision mechatronics, fluidics, and automation supply chains, deep biotech/pharma demand, rigorous quality and regulatory standards, and well-developed service/support networks that speed product commercialization and global scaling.

Table 1. DNA and RNA Synthesizer Industry Chain Analysis

Item

Description

Upstream

Raw Materials & Components

High-purity nucleotide precursors (DNA/RNA building blocks), coupling reagents (for oligonucleotide chain extension), microfluidic chips (for automated, high-throughput synthesis), precision fluidic pumps, optical detection modules (for real-time synthesis quality monitoring).

Technology & IP

Patented oligonucleotide synthesis chemistry (e.g., phosphoramidite method optimizations), microfluidic system design, and software algorithms for sequence-specific synthesis control.

Midstream

Core DNA/RNA Synthesizer Manufacturing & Services

1. Synthesizer Development & Production: Design and assembly of tiered systems (benchtop: small-batch, lab-scale; industrial: high-throughput, large-volume) with integrated automation (AI-driven sequence optimization, error correction).

2. Customization Services: Tailoring synthesizers for niche needs (long-read RNA/DNA synthesis, modified nucleotide integration for therapeutic applications) and high-throughput workflows (for CRO/bioprocessing clients).

3. Post-Sales Support: Maintenance, software updates (protocol expansion), and training for end-user lab teams.

Downstream

Academic Institution

- Applications: Basic life science research (gene cloning, CRISPR sgRNA synthesis), synthetic biology (gene circuit construction), genomics (NGS probe preparation), educational lab projects.

- Needs: Small-batch (10-1000nmol), diverse sequences, flexible modification options, user-friendly operation, cost-effectiveness.

- Equipment Preference: Benchtop synthesizers or shared core facility high-throughput systems.

Pharmaceutical Company

- Applications: Nucleic acid drug R&D (mRNA vaccines, siRNA therapeutics), gene therapy (CRISPR vector synthesis), diagnostic assay production (qPCR primers).

- Needs: Large-scale (μmol-gram-level), GMP-compliant production, high purity (>99.5%), batch consistency, sequence traceability.

- Equipment Preference: Industrial high-throughput synthesizers with integrated GMP data management systems.

Source: Secondary Sources, Press Releases, Expert Interviews and QYResearch, 2025

Table 2. DNA and RNA Synthesizer Industry Policy Analysis

Policy

Description

1

US FDA "Guidance for Industry: CMC Information for Nucleic Acid-Based Gene Therapy Products (2024)"

Mandates that DNA/RNA synthesizers used in GMP production of nucleic acid APIs (e.g., mRNA, siRNA) must include validated process controls (batch tracking, error correction), integrated quality monitoring (real-time purity detection), and data integrity features (audit trails). This raises entry barriers for non-compliant equipment, pushing synthesizer manufacturers to develop GMP-specific models for pharmaceutical clients.

2

EU In Vitro Diagnostic Regulation (IVDR, 2022 Full Implementation)

Classifies synthesizers for diagnostic oligonucleotide production (e.g., NGS probes, qPCR primers) as "ancillary equipment" for IVDR-compliant products. It requires suppliers to provide equipment validation reports (performance, reliability) and sequence traceability documentation, expanding post-sales technical support demands for synthesizer manufacturers.

3

China NMPA "Guidelines for mRNA Vaccine Production Equipment Evaluation (2023)"

Specifies technical standards for synthesizers in mRNA vaccine production: high-throughput (≥100mg/batch mRNA), low nucleotide error rate (

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

This release was published on openPR.